No Carolina / NY / Florida
Ph: 561.316.3330

Canon Medical Offers New Liver Reporting Tool for Ultrasound

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Summation

  • In addition, the system provides standard deviation and interquartile range (IQR) data, as well as a simple visual propagation map, to ensure accurate and confident application of the “Rule of Four” to determine cACLD and for the assessment of other liver pathologies.
  • The recently updated guidelines from Society of Radiologists in Ultrasound introduced the “Rule of Four,” a standardized method of using four different levels of shear wave elastography-based liver stiffness to assess the probability of cACLD.
  • Canon Medical reminds us that liver disease is one of the major challenges in imaging today, and accurately determining compensated advanced chronic liver disease (cACLD) is extremely important in order to define the right treatment path.

December 1, 2020

Canon Medical reminds us that liver disease is one of the major challenges in imaging today, and accurately determining compensated advanced chronic liver disease (cACLD) is extremely important in order to define the right treatment path.

The recently updated guidelines from Society of Radiologists in Ultrasound introduced the “Rule of Four,” a standardized method of using four different levels of shear wave elastography-based liver stiffness to assess the probability of cACLD. To help easily and accurately determine cut off values, Canon Medical Systems USA, Inc.’s premium AplioTM i-series ultrasound platform is now available with software to display the calculated measurement averages from multiple samples of the liver, customizable based on the “Rule of Four.”

The program uses measurements obtained with Shear Wave Elastography, Canon Medical’s technology that provides a quantitative measure and dynamic visual display of tissue stiffness in the liver. In addition, the system provides standard deviation and interquartile range (IQR) data, as well as a simple visual propagation map, to ensure accurate and confident application of the “Rule of Four” to determine cACLD and for the assessment of other liver pathologies.

“The new guidelines from SRU reinforce the importance of quickly and accurately determining cACLD, so that clinicians can chart the right course for patient care,” said Dan Skyba, managing director, Ultrasound Business Unit, Canon Medical Systems USA, Inc. “At Canon Medical, it doesn’t get much easier than automatically calculating that average measurement of tissue stiffness, with our Shear Wave Elastography plus this new liver reporting tool.”

The Aplio i-series will be showcased at this year’s virtual Radiological Society of North America (RSNA), at Canon Medical’s unique, immersive booth experience.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Sphere Fluidics Awarded Gold Accreditation by Investors in People

Dale Levitzke, CEO of Sphere Fluidics, expressed his pride in the achievement: "Receiving the Gold Investors in People Award is a significant milestone for Sphere Fluidics. It recognizes the dedication and hard work of our entire team in creating a workplace where people feel valued, supported, and empowered to reach their full potential. This award is not just a tribute to our HR practices, but a testament to our commitment to nurturing a culture of excellence and continuous improvement."

Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership

Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, and Takara Bio USA, Inc. (“Takara Bio USA”), a wholly-owned subsidiary of Takara Bio Inc., today announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS...

CERo Therapeutics Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

CERo Therapeutics is continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA

By using this website you agree to accept Medical Device News Magazine Privacy Policy